Key points are not available for this paper at this time.
Design
Multi-center retrospective pilot study
Molecular subtyping may refine PMBCL risk stratification; leaves open prospective validation for treatment guidance.
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare subtype of non-Hodgkin lymphoma (NHL) that accounts for 2–4% of NHL cases [1,2]. It most commonly presents as a locally invasive anterior...
No takes yet. Share an insight, caveat, or question.
Superdock et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: